Literature DB >> 9484967

Quantitative assessment of circulating antigens in human lymphatic filariasis: a field evaluation of monoclonal antibody-based ELISA using blood collected on filter strips.

P Lalitha1, M Ravichandran, S Suba, P Kaliraj, R B Narayanan, K Jayaraman.   

Abstract

OBJECTIVE: To quantify circulating antigens in individuals with lymphatic filariasis by means of an ELISA using blood on filter strips.
METHOD: Circulating antigens in filarial patients and normal individuals living in an area endemic for W. bancrofti infection in Madras, India were estimated using a monoclonal antibody-based ELISA.
RESULTS: All microfilaraemics showed positivity to circulating antigens whereas people with chronic pathology and 80% of the endemic normals tested negative. The antigen levels in the blood collected in the night and during day time showed positivity and there was no difference in the antigen concentration. The results of the antigen levels collected onto filter strips correlated with their corresponding plasma antigen levels (r = 0.83). In microfilaraemics, DEC treatment did not alter the levels of circulating antigens for up to one month.
CONCLUSIONS: We conclude that this monoclonal antibody-based ELISA using filter strips may be used in day time and replace the existing routine night blood surveys in our endemic area in India.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484967     DOI: 10.1046/j.1365-3156.1998.00170.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  11 in total

1.  Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen.

Authors:  Cédric B Chesnais; François Missamou; Sébastien D S Pion; Jean Bopda; Frédéric Louya; Andrew C Majewski; Gary J Weil; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2013-09-09       Impact factor: 2.345

2.  Cloning and characterization of a novel immunogenic protein 3 (NIP3) from Brugia malayi by immuno screening of a phage-display cDNA expression library.

Authors:  Munirathinam Gnanasekar; Balumuri Padmavathi; Kalyanasundaram Ramaswamy
Journal:  Parasitol Res       Date:  2005-06-11       Impact factor: 2.289

3.  Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis.

Authors:  Christiana Immanuel; Aparnaa Ramanathan; Malathi Balasubramaniyan; Vishal Kishor Khatri; Nitin Purushottam Amdare; Donthamsetty Nageswara Rao; Maryada Venkata Rami Reddy; Kaliraj Perumal
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

4.  Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors:  Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

5.  Immunomonitoring followed by optimal dec therapy for successful management of clinical filariasis in an endemic area.

Authors:  B C Harinath; M V Reddy; R Alli; V K Mehta; P Chaturvedi; K R Patond; S P Kalantri; R K Gupta
Journal:  Indian J Clin Biochem       Date:  1999-07

6.  Filaria associated clinical manifestations in children in an endemic area and morbidity control by immunomonitoring and optimal DEC therapy: Sevagram experience.

Authors:  B C Harinath; M V Reddy; B Bhunia; Y P Bhandari; V K Mehta; P Chaturvedi; N C Prajapati; R K Gupta
Journal:  Indian J Clin Biochem       Date:  2000-08

7.  Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic filariasis.

Authors:  Setty Balakrishnan Anand; Munirathinam Gnanasekar; Mani Thangadurai; Prince R Prabhu; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Parasitol Res       Date:  2007-06-09       Impact factor: 2.289

8.  Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India.

Authors:  Nilima A Kshirsagar; N J Gogtay; B S Garg; P R Deshmukh; D D Rajgor; V S Kadam; P A Thakur; A Gupta; N S Ingole; J K Lazdins-Helds
Journal:  Parasitol Res       Date:  2017-08-07       Impact factor: 2.289

9.  Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.

Authors:  Alexander Yaw Debrah; Sabine Mand; Sabine Specht; Yeboah Marfo-Debrekyei; Linda Batsa; Kenneth Pfarr; John Larbi; Bernard Lawson; Mark Taylor; Ohene Adjei; Achim Hoerauf
Journal:  PLoS Pathog       Date:  2006-09       Impact factor: 6.823

10.  Relative Performance and Predictive Values of Plasma and Dried Blood Spots with Filter Paper Sampling Techniques and Dilutions of the Lymphatic Filariasis Og4C3 Antigen ELISA for Samples from Myanmar.

Authors:  Jesse Masson; Jan Douglass; Maureen Roineau; Khin Saw Aye; Kyi May Htwe; Jeffrey Warner; Patricia M Graves
Journal:  Trop Med Infect Dis       Date:  2017-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.